Statistical Graphics in Late Stage Drug Development

Author(s):  
Julia Wang ◽  
Surya Mohanty
2019 ◽  
Author(s):  
Nicolas Duchemin ◽  
Roberto Buccafusca ◽  
Marc Daumas ◽  
Vincent Ferey ◽  
Stellios Arseniyadis

We report here a general method that allows a highly straightforward access to tertiary difluoromethylated compounds. The strategy relies on a two-step sequence featuring a C-selective electrophilic difluoromethylation and an unprecedented palladium-catalyzed decarboxylative protonation. Considering the generality of the method and the attractive properties offered by the difluoromethyl group, this approach provides a valuable tool for late-stage functionalization and drug development.<br>


2021 ◽  
Author(s):  
Lisa V. Hampson ◽  
Björn Bornkamp ◽  
Björn Holzhauer ◽  
Joseph Kahn ◽  
Markus R. Lange ◽  
...  

2020 ◽  
Vol 32 (6) ◽  
pp. 1421-1426
Author(s):  
J. Dharani ◽  
S. Ravi

Drug development involves assessment of absorption, distribution, metabolism, excretion and toxicity (ADMET) increasingly earlier in the discovery process. in silico ADMET studies are expected to reduce the risk of late-stage attrition of drug development and to optimize screening and testing by looking at only the promising compounds. To this end, several in silico approaches for predicting ADMET properties of compounds from their chemical structure have been developed, ranging from data-based approaches. In this study, ADMET prediction has been done for 20 compounds from the plant Cyanthillium cinereum extracts. Some of the compounds were predicted to be non-toxic.


2019 ◽  
Author(s):  
Nicolas Duchemin ◽  
Roberto Buccafusca ◽  
Marc Daumas ◽  
Vincent Ferey ◽  
Stellios Arseniyadis

We report here a general method that allows a highly straightforward access to tertiary difluoromethylated compounds. The strategy relies on a two-step sequence featuring a C-selective electrophilic difluoromethylation and an unprecedented palladium-catalyzed decarboxylative protonation. Considering the generality of the method and the attractive properties offered by the difluoromethyl group, this approach provides a valuable tool for late-stage functionalization and drug development.<br>


2014 ◽  
Vol 275 (3) ◽  
pp. 251-283 ◽  
Author(s):  
L. S. Schneider ◽  
F. Mangialasche ◽  
N. Andreasen ◽  
H. Feldman ◽  
E. Giacobini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document